HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Curative and preventive anticryptosporidium activities of sinefungin in an immunosuppressed adult rat model.

Abstract
An immunosuppressed rat model was used to investigate the anti-Cryptosporidium parvum activity of sinefungin. In infected animals, oral sinefungin therapy resulted in a dose-related suppression of oocyst shedding, which correlated with oocyst disappearance from ileal sections. When administered prior to or on the day of oocyst challenge, sinefungin successfully prevented infection. These data suggest that sinefungin could be considered as a candidate molecule in the treatment of human cryptosporidiosis, considered to be the most significant enteric opportunistic infection in AIDS.
AuthorsP Brasseur, D Lemeteil, J J Ballet
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 37 Issue 4 Pg. 889-92 (Apr 1993) ISSN: 0066-4804 [Print] United States
PMID8494386 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiprotozoal Agents
  • Adenosine
  • sinefungin
Topics
  • Adenosine (analogs & derivatives, therapeutic use)
  • Animals
  • Antiprotozoal Agents (therapeutic use)
  • Cryptosporidiosis (drug therapy, parasitology, prevention & control)
  • Cryptosporidium parvum
  • Dose-Response Relationship, Drug
  • Feces (parasitology)
  • Immunosuppression Therapy
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: